Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucose and amino acid transporters are integral membrane proteins, primarily belonging to the Solute Carrier (SLC) superfamily, that facilitate the movement of essential nutrients across cellular membranes [1]. Glucose transporters include the facilitative GLUT (SLC2) family and the sodium-dependent SGLT (SLC5) family, which are critical for maintaining systemic glucose homeostasis and are major targets in the treatment of type 2 diabetes [2, 4]. Amino acid transporters, such as the Large Neutral Amino Acid Transporter 1 (LAT1/SLC7A5) and Sodium-coupled Neutral Amino Acid Transporters (SNATs/SLC38), regulate protein synthesis, neurotransmission, and metabolic signaling [3]. These transporters are frequently dysregulated in diseases; for instance, SGLT2 is targeted to reduce renal glucose reabsorption, while LAT1 is often overexpressed in various cancers to support rapid cell proliferation [5]. Therapeutic strategies include the use of small molecule inhibitors to block nutrient uptake in cancer or metabolic disease, as well as the design of prodrugs that exploit these transporters for improved bioavailability [1, 3]. Understanding the specific expression patterns and substrate specificities of these transporters is vital for developing targeted therapies and diagnostic tools [1].
Inhibition of glucose reabsorption in the renal proximal tubule via SGLT2; competitive inhibition of large neutral amino acid transport via LAT1; utilization of transporters for the uptake of prodrugs or therapeutic substrates.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier transporters (Glucose and amino acid transporters) (SLC transporters).